Study highlights possibility of using 3D organoids of the cervix to test drugs
A new study modelled chlamydia and HPV co-infection in patient-derived ectocervix organoids to reveal distinct cellular reprogramming.
List view / Grid view
A new study modelled chlamydia and HPV co-infection in patient-derived ectocervix organoids to reveal distinct cellular reprogramming.
Researchers have successfully generated organoids in suspension, offering the possibility of larger-scale experiments to study human development and disease.
Researchers have identified potential age-related macular degeneration drugs using a novel stem-cell based research tool.
Researchers have made a respiratory model of COVID-19, made from patient-derived stem cells, to understand how the virus affects respiration and which could be used to test possible drugs.
Scientists have developed a multi-organoid system from stem cells that can replicate the liver-islet axis in type 2 diabetes.
Learn about the high-content analysis system that provides high-quality three-dimensional imaging for enhanced live cell analysis.
Scientists identified three prototypical RNA-expression states and revealed differences in their susceptibility to a variety of cancer drugs.
Scientists develop organoid models of neuroendocrine prostate cancer to study EZH2 inhibitors and reveal a potential new target.
The European Medicines Agency is promoting three principles – replace, reduce and refine – to reduce animal testing in medicine development.
This article delves into research at the University of California Los Angeles, US, where stem-cell derived brain organoids that can mimic electrical activity have been developed.
Researchers have established an organoid biobank to search for genes that are essential for the spreading of SARS-CoV-2 infection.
A new model that closely resembles aged lung epithelium in idiopathic pulmonary fibrosis has been developed, possibly leading to treatments.
Scientists have developed brain organoids that recapitulate the head size of autism patients to study the condition as well as possible therapies.
Nanoengineers have developed a high-throughput bioprinter that 3D prints at record speed, potentially accelerating drug development.
A study has shown that inhibiting the REST gene boosted insulin-producing cells during early pancreas development in animals.